QR-koodi

Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis

<b>Background:</b> Interstitial lung diseases (ILDs) encompass a diverse group of disorders affecting the lung interstitium, leading to inflammation, fibrosis, and impaired respiratory function. Currently, the identification of new diagnostic and prognostic biomarkers for ILDs turns out to be necess...

Täydet tiedot

Tallennettuna:
Päätekijät: Piera Soccio, Giorgia Moriondo, Miriana d’Alessandro, Giulia Scioscia, Laura Bergantini, Sara Gangi, Pasquale Tondo, Maria Pia Foschino Barbaro, Paolo Cameli, Elena Bargagli, Donato Lacedonia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI AG 2024-01-01
Sarja:Biomedicines
Aiheet:
IPF
KL-6
progression
progressive fibrosis
non-progressive fibrosis
biomarkers
Linkit:https://www.mdpi.com/2227-9059/12/2/269
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia